Johnson & Johnson claimed its Covid-19 booster shot is 94% reliable when administered 2 months ~ the first dose.It likewise increases antibody levels by 4 to 6 times compared with one shot alone, J&J said.A J&J booster dose given six months out from the first shot appears to be perhaps even much more protective against Covid, the company said.

You are watching: How effective is j&j vaccine


Johnson & Johnson claimed Tuesday its Covid-19 booster shot is 94% reliable when administered 2 months after the very first dose in the unified States. It additionally said the booster rises antibody levels by 4 to 6 times contrasted with one shooting alone.

A J&J booster dose given six months out from the an initial shot appears to be potentially even much more protective against Covid, the firm said, generating antitoxin twelvefold greater four weeks after ~ the boost, nevertheless of age.


When given as a booster, the vaccine stayed well tolerated, v side impacts generally continuous with those viewed after the initial dose, follow to J&J.

"We now have generated proof that a booster shot additional increases protection versus COVID-19 and is expected to extend the term of defense significantly," J&J chief clinical officer Dr. Paul Stoffels claimed in a statement.

The new data, listed in a press release, help J&J make a instance to the Food and Drug management to authorize a booster shot to part 14.8 million americans who have actually received the company's single-dose vaccine.

The Biden administration announced plans critical month to role out booster shots for civilization who received the Moderna and Pfizer vaccines. An FDA advisory committee ~ above Friday unanimously recommended Pfizer booster shots to human being age 65 and older and other breakable Americans. A last decision indigenous the company is expected any kind of day now.

U.S. Health and wellness officials said they needed much more data on the J&J vaccine before they can recommend boosters that those shots.


The 94% efficacy rate for the J&J booster shooting is because that the U.S., the company said. Globally, a booster shooting given about two months after the an initial dose is 75% effective against symptomatic infection, follow to the company. It additionally demonstrated 100% effectiveness versus severe and vital disease, the said.

The firm also released data indigenous a real-world study that discovered a single dose that its vaccine provided strong and also long-lasting protection against Covid-related hospitalizations, demonstrating 81% efficiency after several months.

The new data top top a solitary dose will aid the "critical" require "to prioritize protecting as many human being as feasible against hospitalization and also death given the continued spread that COVID-19 and also rapidly emerging variants," the agency said.

See more: How Did The Delta Fire Start The Delta Fire? Hundreds Of Drivers Fled Interstate 5 As The Fast

"A single-shot COVID-19 vaccine the is basic to use, distribute and administer that provides strong and long-lasting defense is an important to vaccinating the global population," Stoffels said.